2 companies list siponimod as a human prescription drug in the openFDA NDC Directory, led by Novartis Pharmaceuticals Corporation, Novartis Pharma Stein AG. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.

Who supplies siponimod active ingredient?

1 company lists siponimod as a bulk ingredient, including Novartis Pharmaceuticals Corporation.

Drug

Who makes siponimod?

2 companies list siponimod as a human prescription drug, including under the names MAYZENT. Forms: tablet, film coated. Routes: oral.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing siponimod

Company	Forms	Application	NDCs	Registered sites
Novartis Pharmaceuticals CorporationSwitzerland	tablet, film coated	NDANDA209884	3	20
Novartis Pharma Stein AG	tablet, film coated	DRUG FOR FURTHER PROCESSING	3	0

Bulk ingredient listings

Novartis Pharmaceuticals CorporationSwitzerland · 1 NDC

Orange Book patents

5 unexpired patents list siponimod as the active ingredient, expiring between Aug 2028 and Apr 2036. Application holder: NOVARTIS PHARMACEUTICALS CORP.

Enquiry

Common questions

Who makes siponimod?: 2 companies list siponimod as a human prescription drug in the openFDA NDC Directory, led by Novartis Pharmaceuticals Corporation, Novartis Pharma Stein AG. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Who supplies siponimod active ingredient?: 1 company lists siponimod as a bulk ingredient, including Novartis Pharmaceuticals Corporation.